You are here
Injection of blood products
Hepatitis C - Injection of blood products Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Claimant Report - Transfusion of Blood or Blood Products [CR9012] Medical Report - Blood Transfusion and Injection of Blood Products - Hepatitis [MR9051] Preliminary questions [10231]
7025 the veteran has had a blood product injection at some time.
10250 the veteran had a blood products injection more than 2 weeks before the clinical onset of hepatitis C. the blood products injection more than 2 weeks before the clinical onset of hepatitis C was screened for hepatitis C. 10253 — the veteran has established the causal connection between the blood product injection and VEA service for the clinical onset of hepatitis C. 10254 — the veteran has established the causal connection between the blood product injection and operational service for the clinical onset of hepatitis C. or 10255 — the veteran has established the causal connection between the blood product injection and eligible service for the clinical onset of hepatitis C. Clinical onset and operational service [10254] or 7029 — the identified illness or injury for which the blood product injection was given is causally related to operational service. Clinical onset and eligible service [10255] or
10256 — the identified illness or injury for which the blood product injection was given is causally related to eligible service.